Literature DB >> 14715413

Monocyte-derived dendritic cells exposed to Der p 1 allergen enhance the recruitment of Th2 cells: major involvement of the chemokines TARC/CCL17 and MDC/CCL22.

Hamida Hammad1, Hermelijn H Smits, Céline Ratajczak, Asokananthan Nithiananthan, Eddy A Wierenga, Geoffrey A Stewart, Alain Jacquet, Andre-Bernard Tonnel, Joël Pestel.   

Abstract

Dendritic cells (DC) are potent antigen - presenting cells that can orientate the immune response towards a Th1 or a Th2 type. DC produce chemokines that are involved in the recruitment of either Th1 cells, such as IP10 (CXCL10), Th2 cells such as TARC (CCL17) and MDC (CCL22), or non-polarized T cells such as RANTES (CCL5) and MIP-lalpha (CCL3). We investigated whether monocyte-derived DC (MD-DC) generated from healthy donors or from patients sensitive to Dermatophagoides pteronyssinus (Dpt) and exposed to the cysteine-protease Der p 1(allergen of Dpt), could upregulate the expression of chemokines involved in type 1 or type 2 T cell recruitment. MD-DC were pulsed with either Der p 1 or with LPS as the control and the chemokines produced were evaluated using ELISA and chemotaxis assays. Der p 1-pulsed DC from allergic patients showed increased TARC (CCL17) and MDC (CCL22) production without modifying IP-10 (CXCL10) release. Der p 1-pulsed DC from healthy donors showed only increased IP-10 (CXCL10) secretion. RANTES (CCL5) and MIP-lalpha (CCL3) production were similarly increased when DC were from healthy or allergic donors. The selective Th2 clone recruitment activity of supernatants from Der p 1-pulsed DC of allergic patients was inhibited by anti-TARC (CCL17) and anti-MDC (CCL22) neutralizing Abs. By using anti-IP10 (CXCL10) blocking Abs, supernatants of Der p 1-pulsed DC from healthy donors were shown to be involved in the recruitment of Th1 cells. These results suggest that in allergic patients exposed to house dust mites, DC may favour the exacerbation of the Th2 response via the increase in type 2 chemokine production. Copyright John Libbey Eurotext 2003.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14715413

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  15 in total

Review 1.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

Review 2.  Functional diversity and plasticity of human dendritic cell subsets.

Authors:  Tomoki Ito; Yong-Jun Liu; Norimitsu Kadowaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

Review 3.  Lipid-cytokine-chemokine cascades orchestrate leukocyte recruitment in inflammation.

Authors:  Christian D Sadik; Andrew D Luster
Journal:  J Leukoc Biol       Date:  2011-11-04       Impact factor: 4.962

4.  Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model.

Authors:  X Wang; M Fujita; R Prado; A Tousson; H-C Hsu; A Schottelius; D R Kelly; P A Yang; Q Wu; J Chen; H Xu; C A Elmets; J D Mountz; C K Edwards
Journal:  Br J Dermatol       Date:  2009-10-15       Impact factor: 9.302

5.  Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity.

Authors:  Simon S Jensen; Monika Gad
Journal:  J Inflamm (Lond)       Date:  2010-07-27       Impact factor: 4.981

Review 6.  An unexpected role for the anaphylatoxin C5a receptor in allergic sensitization.

Authors:  Bart N Lambrecht
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

Review 7.  Inflammatory effect of environmental proteases on airway mucosa.

Authors:  Charles E Reed
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

Review 8.  The Role of Dust Mites in Allergy.

Authors:  Jeffrey D Miller
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

9.  The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial).

Authors:  Hubert Kolb; Kathrin Lückemeyer; Tim Heise; Christian Herder; Nanette C Schloot; Wolfgang Koenig; Lutz Heinemann; Stephan Martin
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

10.  Dextromethorphan inhibits activations and functions in dendritic cells.

Authors:  Der-Yuan Chen; Pei-Shan Song; Jau-Shyong Hong; Ching-Liang Chu; I-Horng Pan; Yi-Ming Chen; Ching-Hsiung Lin; Sheng-Hao Lin; Chi-Chen Lin
Journal:  Clin Dev Immunol       Date:  2013-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.